Peptide
Semaglutide
Semaglutide is used or studied for weight loss; glycemic control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
In depth
How it works
Semaglutide is a GLP-1 receptor agonist — it closely mimics a hormone your gut releases after eating. Activating GLP-1 receptors slows stomach emptying, increases insulin release when blood sugar is high, suppresses glucagon, and signals satiety centers in the brain, which is why appetite reduction and weight loss show up alongside improved blood sugar control.
It is administered as a once-weekly subcutaneous injection, and its long half-life (roughly a week) is what allows that dosing schedule instead of daily dosing like earlier GLP-1 drugs.
What the research shows
Semaglutide is one of the most extensively studied GLP-1 drugs, with FDA approval under three brand names covering different indications: Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management. Cardiovascular outcome trials have also shown a reduced risk of major cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
Systematic reviews of adverse events consistently find gastrointestinal side effects (nausea, diarrhea) as the most common issue, occurring in a meaningful minority of patients, especially during dose escalation.
Detail
Overview
Semaglutide is used or studied for weight loss; glycemic control and related fat loss and metabolic health goals. Potential benefits and safety depend on indication, formulation, dose, and medical supervision.
Benefits, side effects, and protocols
Benefits list
- Weight loss
- glycemic control
Side effects
- Nausea
- GI upset
Vendor protocol
- None listed
Clinical protocol
- None listed
Evidence
- High
- Highly effective obesity drug
Regulatory
- Fda Approved
- Prescription required
Research
Mechanisms
Evidence notes
- High
- Highly effective obesity drug
Administration
Research links
Contraindications
- None listed
Components
- None listed
Regulatory data
- Fda Approved
- Prescription required
Aliases
- None listed
Used in these stacks
Related compounds
Half-life
How long does Semaglutide stay in your system?
Half-life ≈ 1 week — see what remains after any number of days, and when it is practically cleared.
Guides that cover Semaglutide
BPC-157, TB-500, CJC-1295 and ipamorelin: what the FDA has actually published about each, why “removed from Category 2” does not mean cleared, and what is still unlawful to compound.
A “unit” on an insulin syringe is a volume, not an amount of drug. Here is how mg, mcg, mL and units relate — and why copying someone else’s unit count is the most dangerous shortcut in peptides.
The shortages ended, and with them the enforcement discretion that allowed mass compounding of semaglutide and tirzepatide. What FDA actually said, with the dates, and what remains permitted.
SURMOUNT-5 compared them directly over 72 weeks: tirzepatide produced 20.2% weight loss versus 13.7% for semaglutide. What that number does and does not settle.
One year after semaglutide was withdrawn, participants had regained two-thirds of the weight they lost, and their cardiometabolic gains reverted. The withdrawal trials, read honestly.
A 2026 meta-analysis found lean mass falls in absolute terms on GLP-1 drugs while rising as a proportion of body weight. Both statements are true, and they explain the entire argument.
Microdosing semaglutide or tirzepatide is widely discussed and has never been tested in a randomised trial. Here is what exists, what does not, and why the distinction matters.
Facial gauntness after GLP-1 weight loss is caused by the weight loss, not by the drug. The same appearance follows rapid loss by any means — which is what the term obscures.
Terminology on this page
Concepts from the glossary that come up around Semaglutide.
A deliberately modified version of a natural peptide, altered to change its stability, potency, or duration.
A molecule that binds a receptor and activates it, producing the same kind of response as the body’s own signal.
The time it takes for the concentration of a drug in the body to fall by half.
A gut hormone released after eating that amplifies insulin secretion — GLP-1 and GIP are the two main human incretins.
Glucagon-like peptide-1 — an incretin hormone that increases insulin secretion, slows gastric emptying, and reduces appetite.
A hormone co-secreted with insulin that promotes satiety and slows gastric emptying; cagrilintide is a long-acting analog.
The rate at which food leaves the stomach; GLP-1 drugs slow it, which drives both satiety and nausea.
Increasing a dose gradually over weeks to let the body accommodate before reaching the target dose.
The persistent, intrusive mental chatter about food that many people report going quiet on GLP-1 drugs.
Community abbreviations for semaglutide, tirzepatide, retatrutide, and cagrilintide.
Frequently asked questions
Is semaglutide FDA approved?
Yes. Semaglutide has three FDA-approved brand formulations: Ozempic and Rybelsus for type 2 diabetes, and Wegovy for chronic weight management in adults with obesity or overweight with a weight-related condition.
How does semaglutide cause weight loss?
It activates GLP-1 receptors that slow gastric emptying and signal satiety in the brain, reducing appetite and food intake, while also improving insulin secretion and blood sugar regulation.
What is the most common side effect of semaglutide?
Gastrointestinal side effects — nausea, vomiting, and diarrhea — are the most frequently reported, and tend to be most noticeable during dose escalation.
What's the difference between semaglutide and tirzepatide?
Semaglutide activates only the GLP-1 receptor, while tirzepatide is a dual agonist that also activates the GIP receptor. Head-to-head trials have generally shown tirzepatide producing greater average weight loss, though individual response varies.
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing Semaglutide? Check your source before you use anything.